Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Invo BioScience Inc. (INVO : NSDQ)
 
 • Company Description   
INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. It engages in the development and manufacture of its lead product, INVOcell, a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology. INVO Bioscience focuses on selling its product to IVF centers and physicians through distributors, as well as directly to physicians in Europe, Canada, Latin America, and the Middle East.

Number of Employees: 12

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.56 Daily Weekly Monthly
20 Day Moving Average: 32,348 shares
Shares Outstanding: 12.09 (millions)
Market Capitalization: $18.86 (millions)
Beta: -0.40
52 Week High: $5.43
52 Week Low: $1.36
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -11.36% -2.88%
12 Week -48.68% -44.32%
Year To Date -53.15% -44.29%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5582 BROADCAST COURT
-
SARASOTA,FL 34240
USA		 ph: 978-878-9505
fax: -		 info@invobio.com http://www.invobioscience.com
 
 • General Corporate Information   
Officers
Steven Shum - Chief Executive Officer
Andrea Goren - Chief Financial Officer
Matthew Szot - Director
Kevin Doody - Director
Trent Davis - Director

Peer Information
Invo BioScience Inc. (CORR.)
Invo BioScience Inc. (RSPI)
Invo BioScience Inc. (CGXP)
Invo BioScience Inc. (BGEN)
Invo BioScience Inc. (GTBP)
Invo BioScience Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 44984F302
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/15/22
Share - Related Items
Shares Outstanding: 12.09
Most Recent Split Date: 11.00 (0.63:1)
Beta: -0.40
Market Capitalization: $18.86 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.25 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.80 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/15/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.50
Price/Cash Flow: -
Price / Sales: 5.18
EPS Growth
vs. Year Ago Period: 8.00%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -76.20%
vs. Previous Quarter: -94.65%
ROE
03/31/22 - -144.13
12/31/21 - -130.81
09/30/21 - -228.66
ROA
03/31/22 - -70.82
12/31/21 - -66.27
09/30/21 - -105.28
Current Ratio
03/31/22 - -
12/31/21 - 5.03
09/30/21 - 2.49
Quick Ratio
03/31/22 - -
12/31/21 - 4.80
09/30/21 - 2.36
Operating Margin
03/31/22 - -185.16
12/31/21 - -154.22
09/30/21 - -787.86
Net Margin
03/31/22 - -191.70
12/31/21 - -159.96
09/30/21 - -787.94
Pre-Tax Margin
03/31/22 - -
12/31/21 - -159.86
09/30/21 - -806.03
Book Value
03/31/22 - -
12/31/21 - 0.62
09/30/21 - 0.23
Inventory Turnover
03/31/22 - -
12/31/21 - 0.53
09/30/21 - 0.40
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©